3-Hydroxyphthaloyl-beta-lactoglobulin

Drug Profile

3-Hydroxyphthaloyl-beta-lactoglobulin

Alternative Names: 3-hydroxyphthalic anhydride treated beta-lactoglobulin; 3HP-beta-LG

Latest Information Update: 30 Apr 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antivirals
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Herpes simplex virus infections; HIV infections

Most Recent Events

  • 01 Jul 1998 A study has been added to the antimicrobial activity section
  • 29 Aug 1996 New profile
  • 29 Aug 1996 Preclinical development for Herpes simplex virus infections in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top